Role of autoantibodies in type 1 diabetes - PubMed (original) (raw)
Review
doi: 10.2741/2195.
Affiliations
- PMID: 17127428
- DOI: 10.2741/2195
Review
Role of autoantibodies in type 1 diabetes
Dongmei Miao et al. Front Biosci. 2007.
Abstract
Type 1A, the immune mediated form of diabetes, is a relatively common disorder that develops in genetically susceptible individuals. The disease is associated with a series of anti-islet autoantibodies and the autoantibodies can be present for years prior to the onset of hyperglycemia. In general it is thought that type 1A diabetes is T cell mediated, but there is evidence from studies in the NOD mouse model that antibodies and B-lymphocytes contribute to pathogenesis. In man evidence is lacking that transplacental passage of anti-islet antibodies increases disease risk. Well characterized, high throughput autoantibody assays (tested in a series of international workshops) are now available, and are the mainstays of prediction of type 1A diabetes, diagnosis of the immune mediated form of diabetes, and are important for the design of trials for the prevention of type 1A diabetes. In addition to anti-islet autoantibodies, patients with type 1A diabetes develop a series of associated autoimmune disorders that are usually detected with screening for additional autoantibodies (e.g. anti-thyroid, anti-transglutaminase, anti-21 hydroxylase, anti-parietal cell). At present it is possible to predict the development of type 1A diabetes and prevent the disorder in animal models, but we lack proven therapies for disease prevention in man. The ability to detect specific anti-islet autoantibodies provides the foundation for developing and testing these preventive therapies.
Similar articles
- T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus.
Dotta F, Dionisi S, Viglietta V, Tiberti C, Matteoli MC, Cervoni M, Bizzarri C, Marietti G, Testi M, Multari G, Lucentini L, Di Mario U. Dotta F, et al. Eur J Endocrinol. 1999 Sep;141(3):272-8. doi: 10.1530/eje.0.1410272. Eur J Endocrinol. 1999. PMID: 10474125 - Dual-parameter model for prediction of type I diabetes mellitus.
Eisenbarth GS, Gianani R, Yu L, Pietropaolo M, Verge CF, Chase HP, Redondo MJ, Colman P, Harrison L, Jackson R. Eisenbarth GS, et al. Proc Assoc Am Physicians. 1998 Mar-Apr;110(2):126-35. Proc Assoc Am Physicians. 1998. PMID: 9542768 - Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?
Shtauvere-Brameus A, Falorni A, Rumba I, Sanjeevi CB. Shtauvere-Brameus A, et al. Ann N Y Acad Sci. 2002 Apr;958:259-62. doi: 10.1111/j.1749-6632.2002.tb02982.x. Ann N Y Acad Sci. 2002. PMID: 12021119 - Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
Leslie RD, Atkinson MA, Notkins AL. Leslie RD, et al. Diabetologia. 1999 Jan;42(1):3-14. doi: 10.1007/s001250051105. Diabetologia. 1999. PMID: 10027571 Review. No abstract available.
Cited by
- Neutrophils Actively Contribute to Obesity-Associated Inflammation and Pathological Complications.
Uribe-Querol E, Rosales C. Uribe-Querol E, et al. Cells. 2022 Jun 10;11(12):1883. doi: 10.3390/cells11121883. Cells. 2022. PMID: 35741012 Free PMC article. Review. - β-cell self-destruction and extremely complicated and still unknown etiopathogenesis of type 1 diabetes.
Chwalba A, Pilśniak A, Otto-Buczkowska E. Chwalba A, et al. Pediatr Endocrinol Diabetes Metab. 2021;27(1):47-50. doi: 10.5114/pedm.2020.103058. Pediatr Endocrinol Diabetes Metab. 2021. PMID: 33599437 Free PMC article. Review. - Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases.
Opazo MC, Ortega-Rocha EM, Coronado-Arrázola I, Bonifaz LC, Boudin H, Neunlist M, Bueno SM, Kalergis AM, Riedel CA. Opazo MC, et al. Front Microbiol. 2018 Mar 12;9:432. doi: 10.3389/fmicb.2018.00432. eCollection 2018. Front Microbiol. 2018. PMID: 29593681 Free PMC article. Review. - Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology.
Wenzel K, Schulze-Rothe S, Müller J, Wallukat G, Haberland A. Wenzel K, et al. PLoS One. 2018 Feb 9;13(2):e0192615. doi: 10.1371/journal.pone.0192615. eCollection 2018. PLoS One. 2018. PMID: 29425252 Free PMC article. - Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Nonobese Diabetic Mice.
Hanes WM, Olofsson PS, Kwan K, Hudson LK, Chavan SS, Pavlov VA, Tracey KJ. Hanes WM, et al. Mol Med. 2015 Nov;21(1):702-708. doi: 10.2119/molmed.2015.00142. Epub 2015 Aug 17. Mol Med. 2015. PMID: 26322849 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI15416/AI/NIAID NIH HHS/United States
- AI50964/AI/NIAID NIH HHS/United States
- DK057538/DK/NIDDK NIH HHS/United States
- DK32083/DK/NIDDK NIH HHS/United States
- DK32493/DK/NIDDK NIH HHS/United States
- M01 RR00051/RR/NCRR NIH HHS/United States
- M01 RR00069/RR/NCRR NIH HHS/United States
- P30 DK57516/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Other Literature Sources
Medical